Events

CERIS event - Countering online identity theft and fake information
MAY
Thu
15
09:00 - 17:00

This was 6 months ago

Location

Brussels

Programmes
Security

In today’s digital age, online identity theft and the proliferation of fake information pose pressing challenges to individuals, organisations, and governments worldwide. As technology continually evolves, so do the tactics employed by malicious actors, leading to increasingly sophisticated methods of stealing personal information and disseminating false narratives.

This workshop will explore these critical issues, exploring current trends, emerging threats, and potential solutions within the context of the EU’s security research and innovation efforts.

Event organiser: CERIS - Community for European Research and Innovation for Security

For more information on this event and to register, please visit the dedicated event page via this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.